Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Interim Statement of Loss and Comprehensive Loss (Unaudited)

v3.8.0.1
Consolidated Condensed Interim Statement of Loss and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Expenses    
Research and development $ 1,934,643 $ 732,729
General and administrative 744,621 1,316,639
Operating Expenses 2,679,264 2,049,368
Other loss (income)    
Change in fair value of stock option and derivative liabilities (56,568) 225,688
Foreign exchange loss 43,866 15,324
Interest income (156) (41)
Other (income) loss (12,858) 240,971
Net and comprehensive loss for the period 2,666,406 2,290,339
Computation of basic loss per share    
Net and comprehensive loss for the year 2,666,406 2,290,339
Series B Preferred stock dividend 41,666 307,298
Computation of basic loss per share $ 2,708,072 $ 2,597,637
Basic and fully diluted loss per share $ 0.18 $ 0.23
Basic weighted average number of shares 15,292,781 11,301,989